Weight Loss

These are the peptides behind much of today's obesity and metabolic research. Semaglutide acts at the GLP-1 receptor, Tirzepatide at the GLP-1 and GIP receptors, Retatrutide at the GLP-1, GIP and glucagon receptors, and Survodutide at the GLP-1 and glucagon receptors. Cagrilintide is a long-acting amylin analog, and CagriSema pairs it with Semaglutide in one vial. Adipotide is a peptidomimetic studied in adipose-tissue vasculature research, and AOD-9604 is a modified fragment of human growth hormone.

8 products

Retatrutide, 20 mg

≥99% purity

Weight Loss

Retatrutide

Triple receptor agonist peptide

10 · 15 · 20 · 30 · 40 · 50 mg

from$121

Tirzepatide, 10 mg

≥99% purity

Weight Loss

Tirzepatide

Acylated dual incretin analog peptide

10 · 15 · 20 · 30 · 50 · 60 mg

from$117

Semaglutide, 10 mg

≥99% purity

Weight Loss

Semaglutide

Acylated GLP-1 analog peptide

10 · 20 · 30 mg

from$117

Out of stock

AOD-9604, 5 mg

≥99% purity

Metabolic

AOD-9604

hGH(177-191) analog · 16 amino acids

2 · 5 · 10 mg

from$32

Sold out

Out of stock

≥99% purity

Weight Loss

Survodutide

Dual GLP-1 / glucagon receptor agonist peptide

10 mg

$180

Sold out

Out of stock

≥99% purity

Weight Loss

Cagrilintide

Long-acting acylated amylin analog peptide

5 · 10 mg

from$108

Sold out

Out of stock

Weight Loss

CagriSema

Pre-mixed Cagrilintide + Semaglutide · one vial

5 · 10 mg

from$96

Sold out

Out of stock

≥99% purity

Weight Loss

Adipotide

Peptidomimetic (FTPP) · adipose-vasculature research

2 · 5 mg

from$68

Sold out